相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Polymer-conjugated glucosamine complexed with boric acid shows tumor-selective accumulation and simultaneous inhibition of glycolysis
Waliul Islam et al.
BIOMATERIALS (2021)
Weak Interplay between Hydrophobic Part of Water-soluble Polymers and Serum Protein
Shin Takano et al.
CHEMISTRY LETTERS (2021)
The 35th Anniversary of the Discovery of EPR Effect: A New Wave of Nanomedicines for Tumor-Targeted Drug Delivery-Personal Remarks and Future Prospects
Hiroshi Maeda
JOURNAL OF PERSONALIZED MEDICINE (2021)
A Critical Review of Radiation Therapy: From Particle Beam Therapy (Proton, Carbon, and BNCT) to Beyond
Yoshitaka Matsumoto et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
EPR-Effect Enhancers Strongly Potentiate Tumor-Targeted Delivery of Nanomedicines to Advanced Cancers: Further Extension to Enhancement of the Therapeutic Effect
Waliul Islam et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Probing the interactions of GlcNH2 with boric acid via NMR spectroscopy
Lingyu Jia et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2021)
Simple Derivatization of RAFT-Synthesized Styrene-Maleic Anhydride Copolymers for Lipid Disk Formulations
Kevin M. Burridge et al.
BIOMACROMOLECULES (2020)
The entry of nanoparticles into solid tumours
Shrey Sindhwani et al.
NATURE MATERIALS (2020)
Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers
Jun Fang et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Glucosamine inhibits IL-1β expression by preserving mitochondrial integrity and disrupting assembly of the NLRP3 inflammasome
Hsiao-Wen Chiu et al.
SCIENTIFIC REPORTS (2019)
Augmentation of EPR Effect and Efficacy of Anticancer Nanomedicine by Carbon Monoxide Generating Agents
Jun Fang et al.
PHARMACEUTICS (2019)
Arterial thromboembolic events preceding the diagnosis of cancer in older persons
Babak B. Navi et al.
BLOOD (2019)
Engineered nanomedicines with enhanced tumor penetration
Jianxun Ding et al.
NANO TODAY (2019)
N-(2-hydroxypropyl)methacrylamide polymer conjugated pyropheophorbide-a, a promising tumor-targeted theranostic probe for photodynamic therapy and imaging
Jun Fang et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)
Augmentation of the Enhanced Permeability and Retention Effect with Nitric Oxide-Generating Agents Improves the Therapeutic Effects of Nanomedicines
Waliul Islam et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs
Hiroshi Maeda et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
Polymer therapeutics and the EPR effect
Hiroshi Maeda
JOURNAL OF DRUG TARGETING (2017)
Polymers as Drugs-Advances in Therapeutic Applications of Polymer Binding Agents
Eric F. Connor et al.
JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY (2017)
Risk of Arterial Thromboembolism in Patients With Cancer
Babak B. Navi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer
Helen Lee et al.
CLINICAL CANCER RESEARCH (2017)
Glucosamine induces ER stress by disrupting lipid-linked oligosaccharide biosynthesis and N-linked protein glycosylation
Daniel R. Beriault et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2017)
A Retrospective 30Years After Discovery of the Enhanced Permeability and Retention Effect of Solid Tumors: Next-Generation Chemotherapeutics and Photodynamic TherapyProblems, Solutions, and Prospects
Hiroshi Maeda et al.
MICROCIRCULATION (2016)
Low-molecular-weight polymer-drug conjugates for synergistic anticancer activity of camptothecin and doxorubicin combinations
Kathryn M. Camacho et al.
NANOMEDICINE (2016)
Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity
Hiroshi Maeda
ADVANCED DRUG DELIVERY REVIEWS (2015)
Anti-Vascular Endothelial Growth Factor Therapy in Breast Cancer: Game Over?
George W. Sledge
JOURNAL OF CLINICAL ONCOLOGY (2015)
Anti-cancer activity of glucosamine through inhibition of N-linked glycosylation
Viktor Chesnokov et al.
CANCER CELL INTERNATIONAL (2014)
Two step mechanisms of tumor selective delivery of N-(2-hydroxypropyl) methacrylamide copolymer conjugated with pirarubicin via an acid-cleavable linkage
Hideaki Nakamura et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Therapeutic efficacy of boron neutron capture therapy mediated by boron-rich liposomes for oral cancer in the hamster cheek pouch model
Elisa M. Heber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Smart polymers for the controlled delivery of drugs - a concise overview
Honey Priya James et al.
ACTA PHARMACEUTICA SINICA B (2014)
Questions on the role of the EPR effect in tumor targeting
Kinam Park
JOURNAL OF CONTROLLED RELEASE (2013)
Analysis on the current status of targeted drug delivery to tumors
Il Keun Kwon et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting
Hiroshi Maeda
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2012)
Intracellular uptake and behavior of two types zinc protoporphyrin (ZnPP) micelles, SMA-ZnPP and PEG-ZnPP as anticancer agents; unique intracellular disintegration of SMA micelles
Hideaki Nakamura et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects
Hiroshi Maeda
BIOCONJUGATE CHEMISTRY (2010)
Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
David W. Miles et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Polymers for Drug Delivery Systems
William B. Liechty et al.
ANNUAL REVIEW OF CHEMICAL AND BIOMOLECULAR ENGINEERING, VOL 1 (2010)
Boron neutron capture therapy at the crossroads: Challenges and opportunities
Rolf F. Barth
APPLIED RADIATION AND ISOTOPES (2009)
Enhanced delivery of macromolecular antitumor drugs to tumors by nitroglycerin application
Takahiro Seki et al.
CANCER SCIENCE (2009)
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
H. Maeda et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
Jolien Tol et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications
H Maeda et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2003)
分享论文
